EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice
Background:
We have previously shown that EphrinA1/EphA expression profile changes in response to myocardial infarction (MI), exogenous EphrinA1-Fc administration following MI positively influences wound healing, and that deletion of the EphA2 Receptor (EphA2-R) exacerbates injury and remodeling. To determine whether or not ephrinA1-Fc would be of therapeutic value in the hyperglycemic infarcted heart, it is critical to evaluate how ephrinA1/EphA signaling changes in the hyperglycemic myocardium in response to MI.
Methods:
Streptozotocin (STZ)-induced hyperglycemia in wild type (WT) and EphA2-receptor mutant (EphA2-R-M) mice was initiated by an intraperitoneal injection of STZ (150 mg/kg) 10 days before surgery. MI was induced by permanent ligation of the left anterior descending coronary artery and analyses were performed at 4 days post-MI. ANOVAs with Student-Newman Keuls multiple comparison post-hoc analysis illustrated which groups were significantly different, with significance of at least p
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Augustin DuSablonSusan KentAnita CoburnJitka Virag Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Endocrinology | Heart | Heart Attack | Students | Universities & Medical Training